Skip to content

Liraglutide studies: 1,219 papers with results

Page 12 of 25

  1. Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.

    Monami M · Acta diabetologica · 2017

    Systematic review · 4 results

  2. Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

    Luo Q · Frontiers in medicine · 2022

    Systematic review · 18 results

  3. The effectiveness and safety of liraglutide in treating overweight/obese patients with polycystic ovary syndrome: a meta-analysis.

    Ge JJ · Journal of endocrinological investigation · 2022

    Systematic review · 8 results

  4. Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis.

    Lian J · Frontiers in endocrinology · 2021

    Systematic review · 2 results

  5. Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis.

    An X · Diabetes, obesity & metabolism · 2025

    Systematic review · 14 results

  6. A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders.

    Au HCT · Journal of affective disorders · 2025

    Systematic review · 8 results

  7. Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.

    Ida S · Heart failure reviews · 2021

    Systematic review · 2 results

  8. Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.

    Esparham A · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024

    Systematic review · 7 results

  9. The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta-analysis.

    Tandon S · Diabetes, obesity & metabolism · 2021

    Systematic review · 3 results

  10. The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic review.

    Valentino K · Journal of psychiatric research · 2025

    Systematic review · 8 results

  11. Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.

    Wong SY · Cardiovascular drugs and therapy · 2024

    Systematic review · 6 results

  12. Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?

    Updike WH · Drugs · 2021

    Systematic review · 10 results

  13. Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes: A systematic review and meta-analysis.

    Li M · Medicine · 2017

    Systematic review · 5 results

  14. Liraglutide for the treatment of type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials.

    Du Q · Advances in therapy · 2014

    Systematic review · 5 results

  15. Evaluation of the risk of fracture in type 2 diabetes mellitus patients with incretins: an updated meta-analysis.

    Kong QX · Endokrynologia Polska · 2021

    Systematic review · 2 results

  16. The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus-A Systematic Review.

    Bica IC · International journal of molecular sciences · 2023

    Systematic review · 2 results

  17. Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity-a systematic review and network meta-analysis.

    Shamim MA · Diabetes, obesity & metabolism · 2024

    Systematic review · 6 results

  18. Liraglutide for the Treatment of Weight Regain After Bariatric Surgery: A Systematic Review and Meta-analysis.

    de Moraes FCA · Obesity surgery · 2024

    Systematic review · 4 results

  19. Safety and efficacy of liraglutide on reducing visceral and ectopic fat in adults with or without type 2 diabetes mellitus: A systematic review and meta-analysis.

    He F · Diabetes, obesity & metabolism · 2023

    Systematic review · 6 results

  20. Pharmacological interventions for addressing pediatric and adolescent obesity: A systematic review and network meta-analysis.

    Yang S · PloS one · 2025

    Systematic review · 5 results

  21. Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials.

    Xue X · International journal of clinical practice · 2016

    Systematic review · 10 results

  22. Comparative efficacy and safety of glucose-lowering drugs in children and adolescents with type 2 diabetes: A systematic review and network meta-analysis.

    Wu S · Frontiers in endocrinology · 2022

    Systematic review · 4 results

  23. Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.

    Wang L · Pharmacological research · 2021

    Systematic review · 13 results

  24. GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis.

    Tan YW · Langenbeck's archives of surgery · 2025

    Systematic review · 13 results

  25. Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis.

    Ren X · Scientific reports · 2025

    Systematic review · 29 results

  26. Comparison of weight loss and adverse events of obesity drugs in children and adolescents: a systematic review and meta-analysis.

    Zhao G · Expert review of clinical pharmacology · 2022

    Systematic review · 2 results

  27. Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction.

    Hamad F · Current diabetes reviews · 2021

    Systematic review · 7 results

  28. Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis.

    Karimi MA · Frontiers in pharmacology · 2025

    Systematic review · 26 results

  29. Efficacy of Glucagon-like Peptide-1 Receptor Agonists in Overweight/Obese and/or T2DM Adolescents: A Meta-analysis Based on Randomized Controlled Trials

    Dai M · Journal of clinical research in pediatric endocrinology · 2024

    Systematic review · 6 results

  30. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.

    Fan S · Revista espanola de enfermedades digestivas · 2020

    Systematic review · 7 results

  31. The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies.

    Baptista A · The European journal of health economics : HEPAC : health economics in prevention and care · 2017

    Systematic review · 2 results

  32. Effectiveness of pharmacological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline.

    Wahi G · Pediatric obesity · 2024

    Systematic review · 10 results

  33. Once-Weekly Semaglutide Versus Once-Daily Liraglutide for Weight Loss in Adults: A Meta-Analysis of Randomized Controlled Trials.

    Hashmi TM · Clinical and translational science · 2025

    Systematic review · 10 results

  34. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis.

    Hegde NC · General hospital psychiatry · 2024

    Systematic review · 1 result

  35. Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs.

    Zhao Y · Medicine · 2023

    Systematic review · 9 results

  36. Side effect profile of pharmacologic therapies for liver fibrosis in nonalcoholic fatty liver disease: a systematic review and network meta-analysis.

    Li Y · European journal of gastroenterology & hepatology · 2023

    Systematic review · 3 results

  37. Microvascular Benefits of New Antidiabetic Agents: A Systematic Review and Network Meta-Analysis of Kidney Outcomes.

    Cha AS · The Journal of clinical endocrinology and metabolism · 2021

    Systematic review · 2 results

  38. Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.

    Chen J · Journal of diabetes · 2025

    Systematic review · 4 results

  39. Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta-Analysis.

    Ren Q · Journal of evidence-based medicine · 2025

    Systematic review · 11 results

  40. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.

    Gou H · European journal of pediatrics · 2023

    Systematic review · 15 results

  41. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

    Xia W · Medicine · 2024

    Systematic review · 7 results

  42. Efficacy of liraglutide in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.

    Mali N · BMC endocrine disorders · 2022

    Systematic review · 11 results

  43. Liraglutide reduces systolic blood pressure in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials.

    Zhao D · Clinical and experimental hypertension (New York, N.Y. : 1993) · 2020

    Systematic review · 5 results

  44. Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials.

    Guo J · Frontiers in pharmacology · 2025

    Systematic review · 3 results

  45. Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation.

    Alansari AO · Medicine · 2025

    Systematic review · 7 results

  46. Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis.

    Teng Y · BMC endocrine disorders · 2024

    Systematic review · 10 results

  47. Comparative efficacy and safety of antidiabetic drugs for obese patients with knee osteoarthritis: a network meta-analysis of randomized controlled trials.

    Jiang G · Aging clinical and experimental research · 2025

    Systematic review · 4 results

  48. Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis.

    Alfehaid L · Expert opinion on drug safety · 2026

    Systematic review · 3 results

  49. The effect of liraglutide on renal function in type 2 diabetes: a meta-analysis of randomized controlled studies.

    Luo C · African health sciences · 2022

    Systematic review · 6 results

  50. Liraglutide for the Treatment of Obesity: Analyzing Published Reviews.

    Pastor R · Current pharmaceutical design · 2019

    Systematic review · 2 results

How PepBank reports evidence